Currently, there are 317.87M common shares owned by the public and among those 313.98M shares have been available to trade.
The company’s stock has a 5-day price change of -5.94% and 0.28% over the past three months. MOS shares are trading 3.78% year to date (YTD), with the 12-month market performance down to -20.83% lower. It has a 12-month low price of $23.56 and touched a high of $33.44 over the same period. MOS has an average intraday trading volume of 4.65 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -5.64%, -2.92%, and -6.55% respectively.
Institutional ownership of Mosaic Company (NYSE: MOS) shares accounts for 87.14% of the company’s 317.87M shares outstanding.
It has a market capitalization of $8.10B and a beta (3y monthly) value of 1.34. The stock’s trailing 12-month PE ratio is 22.49, while the earnings-per-share (ttm) stands at $1.13. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.38% over the week and 3.27% over the month.
Analysts forecast that Mosaic Company (MOS) will achieve an EPS of 0.57 for the current quarter, 0.6 for the next quarter and 2.34 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.47 while analysts give the company a high EPS estimate of 0.47. Comparatively, EPS for the current quarter was 0.71 a year ago. Earnings per share for the fiscal year are expected to decrease by -40.34%, and 20.61% over the next financial year. EPS should shrink at an annualized rate of -14.68% over the next five years, compared to 23.51% over the past 5-year period.
Looking at the support for the MOS, a number of firms have released research notes about the stock. Barclays stated their Underweight rating for the stock in a research note on January 21, 2025, with the firm’s price target at $30-$27. Piper Sandler coverage for the Mosaic Company (MOS) stock in a research note released on January 13, 2025 offered a Neutral rating with a price target of $30. CIBC was of a view on December 10, 2024 that the stock is Neutral, while Wolfe Research gave the stock Outperform rating on March 01, 2024, issuing a price target of $39. Piper Sandler on their part issued Underweight rating on February 29, 2024.
